Roger Chammas

41PUBLICATIONS
121CO-AUTHORS
NanomedicinePredictive and prognostic markersGlycoconjugatesGene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Oct 15, 2026
New approach methodologies in nanomedicine: bridging the gap between in silico, in vitro, and in vivo systems.

|Sep 15, 2026
Long Noncoding RNAs (lncRNAs) as Biomarkers of Prognosis in TNBC and Non-TNBC Breast Cancer Patients.

|Aug 27, 2026
miRNA484 and miRNA335-5p as Potential Diagnostic Biomarkers for CA19-9-Negative Pancreatic Ductal Adenocarcinoma.

|Jul 11, 2026
Ensemble machine learning for predicting breast cancer recurrence and mortality using clinical and hemogram data.

|Jun 25, 2026
Aberrant O-glycosylation genes and miR-21-5p targets define a molecular signature of tumor aggressiveness in triple-negative breast cancer.

|Mar 28, 2026
Ganglioside GM3 in the Tumor Microenvironment: Mechanisms of Signaling Regulation and Strategies for Angiogenesis Inhibition.

Min Zeng, Hongda Zhuang, Siyuan Zhao

Pageof 7

Frequent Collaborators

4 joint publications

Alexis Germán Murillo Carrasco

3 joint publications

Dalila Luciola Zanette

3 joint publications

Alexandre Ferreira Ramos

3 joint publications

Mateus Nóbrega Aoki